Pre-IPO investing in Anthropic and OpenAI presents a paradox: both companies command extraordinary valuations and generate significant revenue, yet their paths to public markets diverge sharply on profitability, timeline, and structural risk. Anthropic, valued at $965 billion after its May 2026 Series H round, is targeting an October 2026 Nasdaq listing with a revenue run rate approaching $47 billion and a trajectory toward operating profitability. OpenAI, meanwhile, raised $122 billion in March 2026 at an $852 billion valuation but expects to lose $14 billion in 2026 alone and won’t reach profitability until 2030—a situation CEO Sam Altman has indicated makes him “zero percent excited” about running a public company. For investors considering pre-IPO access through secondary markets or special investment vehicles, the opportunity to own pieces of the companies reshaping artificial intelligence is real, but so are the risks of catching them at inflated valuations just as competition intensifies.
The rush to own pre-IPO shares reflects genuine business momentum: OpenAI’s $2 billion monthly revenue run rate in early 2026 positions it among the fastest-growing companies ever, and it is growing four times faster than Google or Meta did at comparable stages. Yet both companies face an uncomfortable truth. They have already burned through enormous capital, and the market is asking whether their dominance in generative AI will survive the arrival of well-funded competitors with established distribution channels. Google’s Gemini captured 21.5% of web traffic related to AI search in the past year, up from 5.7%, while ChatGPT’s share dropped from 86.7% to 64.5%—a sign that early-mover advantage is not absolute.
Table of Contents
- What You’re Actually Buying When You Invest in Pre-IPO Anthropic and OpenAI
- The Profitability Problem and Long-Term Funding Risk
- Valuation Multiples and the IPO Pricing Trap
- Secondary Markets, Lock-Up Periods, and Access Problems
- Competitive Risks and Market Share Erosion
- Governance and the Non-Profit to For-Profit Transition
- The Timeline Factor and Market Conditions
What You’re Actually Buying When You Invest in Pre-IPO Anthropic and OpenAI
When you purchase pre-ipo shares in either company, you are not buying the same thing you would own on Nasdaq. Secondary market shares trade at prices set by existing shareholders selling to new buyers, often in negotiated private transactions with restrictions. Anthropic and OpenAI both retain the legal right to void secondary market transactions at their discretion, meaning a share you purchased through a secondary platform could theoretically be cancelled if the company decides to tighten its cap table before IPO. This is not theoretical language buried in fine print—it is an explicit contractual right these companies have chosen to maintain, a sign that founders and early investors view pre-IPO secondaries as a gray zone they’d rather police than legitimize.
Anthropic’s ownership structure is clearer for outsiders to parse. The company is on track for its first year of operating profitability while maintaining a run rate of $47 billion in revenue, metrics that will anchor its S-1 filing and IPO pricing. OpenAI’s structure is murkier. The company converted from a non-profit to a for-profit entity, but details about how existing stakeholders—including the non-profit board and the for-profit equity holders—share in future value remain opaque. This governance uncertainty matters because it affects your upside if OpenAI becomes a multi-trillion-dollar business and your downside if the conversion triggers legal disputes or regulatory friction during the IPO process.
The Profitability Problem and Long-Term Funding Risk
The most consequential gap between Anthropic and OpenAI is profitability. Anthropic is approaching operating profit with margins that suggest the company will not need continuous infusions of capital to grow. OpenAI is expected to lose $14 billion in 2026 and will not reach profitability until 2030, according to internal disclosures—four years away. This is not a minor difference in company lifecycle; it is the difference between a scaling business that can fund its own growth and one that will require additional capital raises even after going public.
HSBC published an analysis estimating that OpenAI faces a $207 billion funding gap by 2030, meaning the company will need to raise that much capital from public markets, sovereign wealth funds, or strategic investors to support its roadmap. For shareholders, additional fundraising after IPO means dilution of your percentage ownership. If OpenAI raises $100 billion post-IPO at a higher valuation, your 1% stake becomes 0.5% of a larger pie—and that larger pie must grow faster than the dilution for you to come out ahead. Compare this to Anthropic, which is moving toward self-funding, and the risk profile becomes clearer.
Valuation Multiples and the IPO Pricing Trap
Both companies are pricing themselves against a future that has not arrived. Anthropic’s projected IPO valuation above $1 trillion would represent roughly 20-25x its current $47 billion revenue run rate, assuming the number stays flat. OpenAI’s stated goal is a $1 trillion market cap on a $20 billion annualized revenue run rate, or 50x revenue. For context, Nvidia trades at roughly 25-30x revenue, Microsoft at 8-10x, and Alphabet at 5-6x.
OpenAI’s aspiration of 50x revenue assumes the market will reward AI dominance with a multiple approaching that of the most expensive software companies, even though OpenAI’s path to profit is unclear and costly. History offers a caution. When Meta went public in 2012 at a 22x revenue multiple (extraordinary at the time), the stock traded sideways for 18 months before climbing significantly, because revenue growth had to be explosive to justify the entry price. If Anthropic or OpenAI price at high multiples and revenue growth stalls—even to “merely” 50% annual growth—the stock becomes a poor investment from the IPO price, not because the business is bad, but because the multiple compresses. Secondary market buyers are particularly vulnerable because they are buying at prices already marked up significantly from where these companies last raised venture capital.
Secondary Markets, Lock-Up Periods, and Access Problems
Pre-IPO share access has expanded in the past five years through platforms like Forge, Nasdaq Private Market, Forge Global, and institutional brokerage programs, but it comes with friction and risk. Secondary shares trade at a discount to the company’s latest private valuation (the Series H round for Anthropic, the March 2026 funding for OpenAI) or at a premium if demand is strong. That discount or premium is set by negotiation and supply—not by public markets—so there is no transparent price discovery. You may overpay for Anthropic shares that trade at a premium to the Series H price because of IPO hype, then watch them gap down on the first day of trading when the real market sets a price.
After IPO, restricted stock holders—founders, early employees, investors from early rounds—typically face six-month lock-up periods before they can sell. When those lock-ups expire, supply of shares hits the market. If you own 100 shares purchased in a secondary at $500 each and founders unlock 50 million shares at IPO, the stock may fall 20-30% as early insiders sell to diversify. You should assume that any IPO price will be followed by downward pressure from lock-up expirations, and that pre-IPO shareholders will exit heavily if the stock runs higher than they expected. That downward pressure has historically been acute for companies that priced at high multiples on hype.
Competitive Risks and Market Share Erosion
Neither Anthropic nor OpenAI operates in isolation. The competitive landscape has shifted in ways that pre-IPO valuations may not fully reflect. Google’s Gemini and other models are closing capability gaps, and importantly, they have distribution advantages—Gmail, Search, Chrome, YouTube—that allow Google to make AI accessible to billions of users at zero marginal cost. OpenAI’s ChatGPT currently has stronger brand recognition and user engagement, but Google can sustain losses to take market share in a way that Anthropic cannot. Anthropic’s Series H fundraising and path to profitability make it more defensible than OpenAI in a scenario where AI competition intensifies and margins compress.
The company raised $65 billion because investors believe in its technology and its positioning in enterprise markets. But Anthropic is also newer, smaller, and has no revenue base to compare to OpenAI’s $2 billion monthly run rate. If you are buying Anthropic shares before IPO, you are betting that the company’s research and product differentiation will matter enough that customers will pay premium prices or accept switching costs. If you are buying OpenAI shares, you are betting that first-mover advantage and network effects (millions of users, integrations across products) will sustain high pricing power even as competition arrives. Both are reasonable bets, but neither is certain.
Governance and the Non-Profit to For-Profit Transition
OpenAI’s transition from a non-profit to a for-profit structure created legal complexities that are not fully resolved. The non-profit foundation retains board seats and oversight rights, while new for-profit equity holders are funding the business. In theory, this dual structure ensures that AI safety remains a priority even as shareholders want returns. In practice, it creates ambiguity about who controls the company, how profits are distributed, and what happens if the non-profit and for-profit interests diverge during an IPO or major capital raise.
Sam Altman noted his lack of enthusiasm for running a public company, which is a rare admission from a founder about to go public and raises questions about governance and control. Anthropic’s structure is simpler: it is a for-profit company with a safety and policy team, but no dual-entity complexity. That clarity is an asset, particularly for institutional investors who prefer straightforward cap tables and governance. For pre-IPO buyers, governance risk in OpenAI translates to potential IPO delays, lawsuits related to the non-profit’s role, or executive exits if the founder and the board disagree on strategy. Anthropic, by contrast, poses lower governance risk because Dario and Daniela Amodei and the core team are aligned with the for-profit structure.
The Timeline Factor and Market Conditions
Anthropic is targeting October 2026 for its IPO, pending market conditions. OpenAI originally targeted September–November 2026 but is now “considering potential delay into 2027,” according to statements from leadership. These dates matter because they affect the window in which you can exit secondary shares or the point at which they convert into public shares subject to lock-up periods. If you buy pre-IPO shares in July 2026, believing OpenAI will IPO in November 2026, but the company delays to Q2 2027 due to market conditions or regulatory review, your exit window shifts.
Secondary shares are illiquid, and the path to liquidity is IPO or acquisition. A delay of six months or a year compounds the opportunity cost. If you could have invested in a public company offering 5% annual returns, but instead held illiquid pre-IPO shares for an extra year waiting for IPO, you’ve lost the ability to redeploy capital elsewhere. Both companies have flagged that IPO timing is not fixed, and investors should plan for delays, not certainty.